In 2011, the initial finished scientific trial assessing the prospective of copyright-assisted psychotherapy for alleviating cure-resistant PTSD was published.220 The results were beneficial, and in 2017, copyright was granted “breakthrough therapy” status by the FDA. This designation really helps to expedite the assessment and likely approval